GreenLight Biosciences (GRNAW) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GreenLight Biosciences

    NASDAQ: GRNAW · Real-Time Price · USD
    0.02
    -0.00 (-0.99%)
    At close: Jul 21, 2023, 6:10 PM

    GreenLight Biosciences Ratios and Metrics

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.93 -10.62
    PEG Ratio
    		 -0.03 -0.16
    PS Ratio
    		 24.39 n/a
    PB Ratio
    		 3.24 -40.65
    P/FCF Ratio
    		 -0.95 -11.39
    P/OCF Ratio
    		 -1.14 -13.27
    OCF/S Ratio
    		 -21.42 n/a
    Debt / Equity Ratio
    		 1.67 -2.2
    Quick Ratio
    		 2.01 0.54
    Current Ratio
    		 2.01 0.54
    Asset Turnover
    		 0.04 n/a
    Interest Coverage
    		 -39.76 -44.88
    Return on Equity
    		 -3.48 3.83
    Return on Assets
    		 -1.12 -1.82
    Return on Invested Capital
    		 -1.28 -3.07
    Dividend Yield
    		 n/a n/a
    Payout Ratio
    		 n/a n/a
    Gross Profit Margin
    		 1.00 n/a
    Net Profit Margin
    		 -26.17 n/a
    Pretax Profit Margin
    		 -26 n/a
    Operating Profit Margin
    		 -25.68 n/a
    FCF Margin
    		 n/a n/a
    EBITDA Margin
    		 -24.12 n/a

    Add to Watchlist